DiviDrip · PBYI

PBYI — Puma Biotechnology, Inc.

PBYI is Puma Biotechnology, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $9.60. Market cap: $483M. Capital Quality Rank: 67/100 — Above average.

Stock snapshot

Price$9.60
Market cap$483M
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)67 / 100 · Above average
ROIC (TTM)29.3%
Revenue CAGR (3y)0.1%
Shareholder buyback yield-3.07%
Altman Z-score zoneDistress

About PBYI

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Listed2012Employees179HQLos Angeles, CASectorHealthcareWebsitepumabiotechnology.com

Related non-dividend companies

Other non-dividend stocks investors research alongside PBYI. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is PBYI's current stock price?

PBYI (Puma Biotechnology, Inc.) is currently trading at $9.60.

Does PBYI pay a dividend?

PBYI (Puma Biotechnology, Inc.) does not currently pay a regular dividend.

What is PBYI's Capital Quality Rank?

PBYI has a Capital Quality Rank of 67/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track PBYI in DiviDrip

Add PBYI to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow